Trials
Search / Trial NCT06418828

Patients With Type B Aortic Dissection Returning to Work After Discharge:a Cross-sectional Survey

Launched by FUJIAN MEDICAL UNIVERSITY UNION HOSPITAL · May 14, 2024

Trial Information

Current as of February 19, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at how many patients with a condition called type B aortic dissection are able to return to work after being treated and discharged from the hospital. Type B aortic dissection is a serious condition affecting the large blood vessel that carries blood from the heart. The study aims to gather information from patients to understand their experiences and challenges in getting back to work after their treatment.

To be eligible for this study, participants must be between 18 and 60 years old at the time they were diagnosed, have had a full-time or part-time job, and must have been discharged from the hospital at least six months after successfully receiving treatment for their condition. The trial is currently recruiting participants and is open to all genders. Those who are retired, have severe mental health issues, or are participating in other related studies cannot join. Participants can expect to share their experiences in an interview, which will help researchers understand the impact of this condition on returning to work.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • ( 1 ) TBAD was diagnosed by computed tomography angiography ( CTA ) or magnetic resonance angiography ( MRA ) ; ( 2 ) 18 years ≤ age \< 60 years at diagnosis ; ( 3 ) having full-time or part-time job at the time of diagnosis ; ( 4 ) TBAD patients were discharged after successful treatment and the discharge time was ≥ 6 months ;
  • Exclusion Criteria:
  • ( 1 ) reaching the retirement age 6 months after discharge ; ( 2 ) those with disturbance of consciousness, mental illness, inability to complete the interview independently or under the guidance of the researcher ; ( 3 ) Participate in other related research ; ( 4 ) Clinical end-stage or receiving palliative treatment.

About Fujian Medical University Union Hospital

Fujian Medical University Union Hospital is a leading medical institution in China, dedicated to advancing healthcare through innovative clinical research and comprehensive patient care. As a prominent clinical trial sponsor, the hospital is committed to conducting high-quality studies that contribute to the development of new therapies and medical interventions. With a multidisciplinary team of experienced healthcare professionals and researchers, Fujian Medical University Union Hospital emphasizes ethical standards, patient safety, and scientific rigor in all its clinical trials, fostering collaboration with both local and international research partners to enhance medical knowledge and improve patient outcomes.

Locations

Fuzhou, Fujian, China

People applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Discussion 0